Rewired ERK-JNK Signaling Pathways in Melanoma

Ahn, 1998, A dominant-negative inhibitor of CREB reveals that it is a general mediator of stimulus-dependent transcription of c-fos, Mol. Cell. Biol., 18, 967, 10.1128/MCB.18.2.967 Alsina, 2003, Detection of mutations in the mitogen-activated protein kinase pathway in human melanoma, Clin. Cancer Res., 9, 6419 Angel, 1988, The jun proto-oncogene is positively autoregulated by its product, Jun/AP-1, Cell, 55, 875, 10.1016/0092-8674(88)90143-2 Bain, 2003, The specificities of protein kinase inhibitors: An update, Biochem. J., 371, 199, 10.1042/bj20021535 Bartek, 1993, Molecular pathology of the cell cycle in human cancer cells, Stem Cells, 11, 51, 10.1002/stem.5530110611 Bartek, 1996, The retinoblastoma protein pathway and the restriction point, Curr. Opin. Cell Biol., 8, 805, 10.1016/S0955-0674(96)80081-0 Berns, 2000, RACK1 is up-regulated in angiogenesis and human carcinomas, FASEB J., 14, 2549, 10.1096/fj.99-1038com Bhoumik, 2004, Transcriptional switch by activating transcription factor 2-derived peptide sensitizes melanoma cells to apoptosis and inhibits their tumorigenicity, Proc. Natl. Acad. Sci. USA, 101, 4222, 10.1073/pnas.0400195101 Davis, 2000, Signal transduction by the JNK group of MAP kinases, Cell, 13, 239, 10.1016/S0092-8674(00)00116-1 Davies, 2000, Specificity and mechanism of action of some commonly used protein kinase inhibitors, Biochem. J., 351, 95, 10.1042/0264-6021:3510095 Davies, 2002, Mutations in the B-RAF gene in human cancer, Nature, 417, 949, 10.1038/nature00766 Ding, 2005, Erk associates with and primes GSK-3beta for its inactivation resulting in upregulation of beta-catenin, Mol. Cell, 19, 159, 10.1016/j.molcel.2005.06.009 Downward, 2003, Targeting RAS signaling pathways in cancer therapy, Nat. Rev. Cancer, 3, 11, 10.1038/nrc969 Dumont, 1992, Inhibition of experimental metastasis and cell adhesion of B16F1 melanoma cells by inhibitors of protein kinase C, Cancer Res., 52, 1195 Eferl, 2003, Liver tumor development. c-Jun antagonizes the proapoptotic activity of p53, Cell, 112, 181, 10.1016/S0092-8674(03)00042-4 Errico, 2003, Expression of cyclin-D1 in uveal malignant melanoma, Anticancer Res., 23, 2701 Fuchs, 1996, Phosphorylation-dependent targeting of c-Jun ubiquitination by Jun N-kinase, Oncogene, 13, 1531 Gorden, 2003, Analysis of BRAF and N-RAS mutations in metastatic melanoma tissues, Cancer Res., 63, 3955 Goydos, 2005, Detection of B-RAF and N-RAS mutations in human melanoma, J. Am. Coll. Surg., 200, 362, 10.1016/j.jamcollsurg.2004.10.032 Gupta, 2002, ATF1 phosphorylation by the ERK MAPK pathway is required for epidermal growth factor-induced c-jun expression, J. Biol. Chem., 277, 50550, 10.1074/jbc.M209799200 Ivanov, 2001, Cooperation between STAT3 and c-jun suppresses Fas transcription, Mol. Cell, 7, 517, 10.1016/S1097-2765(01)00199-X Johannessen, 2004, What turns CREB on?, Cell. Signal., 16, 1211, 10.1016/j.cellsig.2004.05.001 Johnson, 2002, Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases, Science, 298, 1911, 10.1126/science.1072682 Johnson, 1996, Cellular transformation and malignancy induced by ras require c-jun, Mol. Cell. Biol., 16, 4504, 10.1128/MCB.16.8.4504 Karin, 1995, The regulation of AP-1 activity by mitogen-activated protein kinases, J. Biol. Chem., 270, 16483, 10.1074/jbc.270.28.16483 Laine, 2005, Ubiquitin chains in the ladder of MAPK signaling, Sci. STKE, 281, re5 Li, 2003, Reciprocal regulation of MelCAM and AKT in human melanoma, Oncogene, 22, 6891, 10.1038/sj.onc.1206819 Liu, 2006, NF-kappaB is required for UV-induced JNK activation via induction of PKCdelta, Mol. Cell, 21, 467, 10.1016/j.molcel.2005.12.020 Lopez-Bergami, 2005, RACK1 mediates activation of JNK by protein kinase C, Mol. Cell, 19, 309, 10.1016/j.molcel.2005.06.025 Lopez-Bergami, 2005, Altered Signal Transduction in Melanoma, 119 Maelandsmo, 1996, Involvement of the pRb/p16/cdk4/cyclin D1 pathway in the tumorigenesis of sporadic malignant melanomas, Br. J. Cancer, 73, 909, 10.1038/bjc.1996.181 Maldonado, 2003, Determinants of BRAF mutations in primary melanomas, J. Natl. Cancer Inst., 95, 1878, 10.1093/jnci/djg123 Mathas, 2002, Aberrantly expressed c-Jun and JunB are a hallmark of Hodgkin lymphoma cells, stimulate proliferation and synergize with NF-kappa B, EMBO J., 21, 4104, 10.1093/emboj/cdf389 Mapelli, 1994, Effect of protein kinase C inhibitors on invasiveness of human melanoma clones expressing different levels of protein kinase C isoenzymes, Int. J. Cancer, 57, 281, 10.1002/ijc.2910570225 Minden, 1994, c-Jun N-terminal phosphorylation correlates with activation of the JNK subgroup but not the ERK subgroup of mitogen-activated protein kinase, Mol. Cell. Biol., 14, 6683, 10.1128/MCB.14.10.6683 Molina, 2005, Characterization of an ERK-binding domain in microphthalmia-associated transcription factor and differential inhibition of ERK2-mediated substrate phosphorylation, J. Biol. Chem., 280, 42051, 10.1074/jbc.M510590200 Morton, 2003, A reinvestigation of the multisite phosphorylation of the transcription factor c-Jun, EMBO J., 22, 3876, 10.1093/emboj/cdg388 Murphy, 2006, MAPK signal specificity: The right place at the right time, Trends Biochem. Sci., 31, 268, 10.1016/j.tibs.2006.03.009 Nyormoi, 2003, Transcriptional regulation of metastasis-related genes in human melanoma, Clin. Exp. Metastasis, 20, 251, 10.1023/A:1022991302172 Oka, 2005, Protein kinase C in melanoma, Cancer Metastasis Rev., 24, 287, 10.1007/s10555-005-1578-8 Pardo, 2004, Abnormal cell cycle regulation in primary human uveal melanoma cultures, J. Cell Biochem., 93, 708, 10.1002/jcb.20230 Park, 2004, Heat shock-induced matrix metalloproteinase (MMP)-1 and MMP-3 are mediated through ERK and JNK activation and via an autocrine interleukin-6 loop, J. Invest. Dermatol., 123, 1012, 10.1111/j.0022-202X.2004.23487.x Pollock, 2002, A genome-based strategy uncovers frequent BRAF mutations in melanoma, Cancer Cell, 2, 5, 10.1016/S1535-6108(02)00089-2 Ron, 1994, Cloning of an intracellular receptor for protein kinase C, a homolog of the beta subunit of G proteins, Proc. Natl. Acad. Sci. USA, 91, 839, 10.1073/pnas.91.3.839 Sabbah, 1999, Estrogen induction of the cyclin D1 promoter: Involvement of a cAMP response-like element, Proc. Natl. Acad. Sci. USA, 96, 11217, 10.1073/pnas.96.20.11217 Saito, 2002, Detection of genes expressed in primary colon cancers by in situ hybridisation, overexpression of RACK 1, Mol. Pathol., 55, 34, 10.1136/mp.55.1.34 Satyamoorthy, 1997, Melanoma cell lines from different stages of progression and their biological and molecular analyses, Melanoma Res., 7, S35, 10.1097/00008390-199708001-00007 Satyamoorthy, 2003, Constitutive mitogen-activated protein kinase activation in melanoma is mediated by both BRAF mutations and autocrine growth factor stimulation, Cancer Res., 63, 756 Sauter, 2002, Cyclin D1 is a candidate oncogene in cutaneous melanoma, Cancer Res., 62, 3200 Schechtman, 2001, Adaptor proteins in protein kinase C-mediated signal transduction, Oncogene, 20, 6339, 10.1038/sj.onc.1204778 Selzer, 2002, Protein kinase C isoforms in normal and transformed cells of the melanocytic lineage, Melanoma Res., 12, 201, 10.1097/00008390-200206000-00003 Seo, 2002, Interactively exploring hierarchical clustering Results, IEEE Computer, 35, 80, 10.1109/MC.2002.1016905 Shaulian, 2002, AP-1 as a regulator of cell life and death, Nat. Cell Biol., 4, 131, 10.1038/ncb0502-e131 Sprowles, 2005, c-Jun controls the efficiency of MAP kinase signaling by transcriptional repression of MAP kinase phosphatases, Exp. Cell Res., 308, 459, 10.1016/j.yexcr.2005.05.010 Tanami, 2004, Involvement of overexpressed wild-type BRAF in the growth of malignant melanoma cell lines, Oncogene, 23, 8796, 10.1038/sj.onc.1208152 Utikal, 2005, Additional Cyclin D(1) gene copies associated with chromosome 11 aberrations in cutaneous malignant melanoma, Int. J. Oncol., 26, 597 Vogt, 2001, Jun, the oncoprotein, Oncogene, 20, 2365, 10.1038/sj.onc.1204443 Wei, 2005, The v-Jun point mutation allows c-Jun to escape GSK3-dependent recognition and destruction by the Fbw7 ubiquitin ligase, Cancer Cell, 8, 25, 10.1016/j.ccr.2005.06.005 Weston, 2002, The JNK signal transduction pathway, Curr. Opin. Genet. Dev., 12, 14, 10.1016/S0959-437X(01)00258-1 Wiggin, 2002, MSK1 and MSK2 are required for the mitogen- and stress-induced phosphorylation of CREB and ATF1 in fibroblasts, Mol. Cell. Biol., 22, 2871, 10.1128/MCB.22.8.2871-2881.2002